The gastrointestinal tract plays a major role in the pathogenesis and pathophysiology ofinfection by the type
The gastrointestinal tract plays a central role in the pathogenesis of the acquired immunodeficiency syndrome (AIDS). The rectal mucosa may represent a major route of horizontal transmission of type 1 human immunodeficiency virus (HIV-1) during anal intercourse. Furthermore, a number of gastrointestinal disorders, including diarrhea, malabsorption, and weight loss, are commonly reported during the course of HIV-1 infection (1) . Although the origin of these gastrointestinal symptoms is still under considerable debate (2) , in many HIV-infected patients the only pathogenic organism identified in the intestine is HIV itself, and this has led to the hypothesis that some of these syndromes may be due to a primary HIV-induced enteropathy (3, 4) . This concept has been supported by two independent findings: (i) both primary and transformed intestinal cells derived from intestine have been infected by HIV in vitro (5, 6) and (ii) HIV viral RNA and core proteins have been detected by in situ hybridization and immunohistochemistry in jejunal and colonic biopsy specimens obtained from HIV-infected individuals (7) (8) (9) .
For these reasons, understanding the mechanisms by which gastrointestinal cells are infected by HIV-1 is of fundamental importance. In vitro infection studies demonstrated a marked heterogeneity in the sensitivity of intestinal cell lines to HIV infection. For example, HT-29, a human colonic adenocarcinoma cell line, was productively infected with several HIV-1 and HIV-2 isolates (5, (10) (11) (12) (13) . In contrast, Caco-2, a cell line obtained from a different human adenocarcinoma, appeared much less sensitive to HIV infection (5) . Infection of HT-29 cells did not involve CD4, the main HIV receptor, since it was not blocked by anti-CD4 monoclonal antibodies OKT4A and Leu-3a (10, 12, 13) , which are known to block infection in T lymphocytes and lymphoid cell lines (14) . Furthermore, CD4 protein or mRNA has not been consistently detected in this cell line (10) . These results suggested that, like several fibroblastic and neural lines (15, 16) , HT-29 cells are infected by an alternative pathway. It was recently reported that a glycolipid related to galactosylceramide (GalCer), an essential component of the neural receptor for HIV surface glycoprotein gpl20 (17, 18) , was expressed by HT-29 cells and that anti-GalCer antibodies inhibited HIV-1 infection in these cells (19) . These results suggested that GalCer (or a close derivative) was involved in HIV-1 entry into the HT-29 cells.
In this report, we extend the original findings by conclusively proving that the glycolipid originally detected in HT-29 cells was indeed GalCer and not a related ceramide monohexoside. Furthermore, by analyzing GalCer expression in two human colon epithelial cell lines and clones derived from them, we demonstrate that the presence of this glycolipid is associated with sensitivity to HIV-1 infection. These results suggest that GalCer, one of the major neutral glycolipids expressed by normal epithelial intestinal cells in humans (20, 21) , may behave as the HIV-1 receptor of gastrointestinal epithelium. (29) . For gpl20 binding, the chromatography plates were first treated for 2.5 min in 0.1% poly(isobutyl methacrylate) in n-hexane. The dried plates were then immersed in 50 mM Tris HCl, pH 7.4/1% gelatin for 2 hr at room temperature to block nonspecific binding. The plates were further incubated with recombinant HIV-1(IIIB)BHlo clone gpl20 (rgpl20, 1 ,ug/ml) for 1 hr at room temperature. Binding of rgpl2O was detected by incubating the plates with a 1:200 dilution of rabbit anti-rgpl20 (a gift from Ray Sweet, SmithKline Beecham) followed by 125I-labeled goat anti-rabbit polyclonal antibodies (2 x 106 cpm/ml). The plates were thoroughly washed in phosphate-buffered saline, dried, and exposed to Kodak x-ray film. (Fig. 1A) , while 20% of HT-29-D4 cells were weakly labeled by the antibody (data not shown). Finally, only rare clusters of HT-29-D9 cells (representing <5% ofthe overall population) demonstrated immunoreactivity with the anti-GalCer antibody (Fig. 1B) .
MATERIALS AND METHODS
Caco-2 cells were also subcloned into several populations, and using R-Mab we have found some variation in the surface immunoreactivity (data not shown (30) , ruling out contamination as an explanation for the heterogeneity of GalCer expression.
Characterization of GalCer-Related Glycolipids in Human Colonic Epithelial Cells. The GalCer-related glycolipids recognized by the anti-GalCer monoclonal antibody were analyzed by HPTLC. The alkali-stable Folch lower-phase glycolipids were chromatographed on silica-gel plates and then visualized with orcinol. The main glycolipid isolated from HT-29 cells (Fig. 2A, lane 2) was a ceramide monohexoside with the same chromatographic mobility as the lower band of bovine brain GalCer, which was used as a standard (lane 1). This lower band is the form of bovine GalCer containing a-hydroxylated fatty acids, the subspecies that binds gp120 (ref. 18 (Fig. 3 A and B) showed that these cells were able to use galactose as a precursor for the biosynthesis of various glycolipids, including the ceramide monohexoside (arrow) recognized by the anti-GalCer antibody and rgpl20 (Fig. 2) . This radioactive glycolipid was purified by preparative TLC and its sugar moiety was released by acid hydrolysis. The monosaccharide was then identified as galactose by its comigration with a galactose standard on HPTLC (Fig. 3C) . Thus, these results demonstrated that the rgpl20-binding glycolipid extracted from HT-29 cells was GalCer.
Correlation Between GalCer Expression and HIV-1 Infection. To study the sensitivity of HT-29-and Caco-2-derived cell lines to HIV-1 infection, cells were exposed to either IIIB, NDK, or 89.6 isolates of HIV-1 at a multiplicity of infection of 1 TCID50 per cell. Infection was monitored by (i) measurement of p24549 antigen in the culture supematant, (ii) indirect immunofluorescence with a monoclonal antibody against p24wn, and (iii) cocultivation with CD4+ SUP-Ti or CEMx174 cells. At this multiplicity of infection, the macrophage-tropic strain HIV-1(89.6) (26) did not appear to infect any ofthe colonic cell lines used and, thus, served as a control for potential residual inoculum in some of the experiments. HT-29, HT-29-A7, and HT-29-D4 were infected by both IIIB and NDK isolates, and in all cases, p245ag was easily measurable in the supematant (Table 1) . However, the level of p24w production was higher in HT-29 and HT-29-A7 cells, which expressed high levels of GalCer (Fig. 1) . HT-29 and HT-29-A7 cells were also infectable by lower-titer inocula (down to 0.001 TCID50 per cell). In addition to p24gag, the supematants contained virus that was fully infectious for SUP-Ti cells (data not shown). The HT-29-D9 line, which expressed lower levels of GalCer by immunofluorescence (Fig. 1) , was infectable, but virus was detected only after extract was purified and acid-hydrolyzed, and the sugar moiety was identified by chromatography followed by quantitative scanning of the HPTLC plate. A single peak was seen and is shown. Abcissa, migration from origin; ordinate, arbitrary radioactive units. The migration of galactose (Gal) and glucose (Glc) standards is indicated by the arrows. antibodies, similar experiments were performed in the HT-29 cell line. Yahi et al. (19) were able to inhibit infection by two HIV-1 strains (LAV and NDK) with a monoclonal antibody with high activity against GalCer, and they demonstrated the presence of a ceramide monohexoside in lipid extracts of the HT-29 line. In the present study we have further characterized this glycolipid and shown that, like GalCer from brain, it is specifically recognized by rgpl20. Previous experiments have indicated that the presence of galactose on a ceramide is not by itself sufficient to allow binding of rgpl2O (18) . This is supported by the finding that a number of HT-29 neutral glycolipids incorporated radioactive galactose, yet only GalCer bound rgpi20.
Having conclusively shown the presence of a gpl20-binding glycolipid on these intestinal cells, we correlated its expression with the efficiency of HIV-1 infection. Cells that expressed either low or undetectable levels of GalCer (Caco-2 and its subclones) were not infected by HIV-1. Cells Results are based on cell surface detection with anti-Gal Cer Mab (Fig. 1 ) and HPTLC analysis of alkali-stable Folch lower phase glycolipids extracted from the cells (Fig. 2 and 3 ).
tAll colon cell lines were treated with IIIB, NDK, and 89.6 isolates of HIV-1 at an equivalent multiplicity of infection, 1 TCID50 per cell. In all cases, HIV-1 89.6 produced no infection (see text).
t+ +, p24gag >5000 pg/ml of cultured supernatant of colon cells 3 weeks postinfection; +, 10 pg/ml c p24gag < 1000 pg/ml and virus was rescued by cocultivation with SUP-Ti or CEMx174 cells; ±, p24gag < 10 pg/ml but virus was rescued by cocultivation; -, p24 < 10 pg/ml and virus was not rescued by cocultivation. §Antibodies were used at a concentration of 20 ,ug/ml as described in Materials and Methods. ND, not done.
that expressed high levels of GalCer (HT-29, HT-29-A7, and, to a lesser extent, HT-29-D4) were productively infected by HIV-1, and the infection was blocked by anti-GalCer antibodies. The last clonal cell line, HT-29-D9, appeared very heterogeneous for GalCer expression (=5% positive cells stained by immunofluorescence) and was less sensitive to HIV-1 infection. This cell line did not produce p24ww in the supernatant ofinfected cells, and virus was rescued only after cocultivation with CD4+ cell lines, much like other infectable CD4-lines (15, 16) . Since GalCer was detected in HT-29-D9 extracts (Fig. 2) , it is possible that the relative inefficiency of HIV-1 infection in these cells was the consequence of a reduced accessibility of the glycolipid in the plasma membrane (32, 33 ).
The association between the level of GalCer expression and the infectability of CD4-colonic cell lines supports the hypothesis that this glycolipid behaves as an alternative receptor for HIV-1. GalCer is one of the major neutral glycolipids found in epithelial cells from human small intestine (20) and colon (21) , as well as transformed cell lines, and we recently found that rgpl20 specifically binds GalCer from normal human ileal and colonic mucosal epithelium with a specificity similar to that found with HT-29 cells (unpublished work). The presence of a putative HIV-1 receptor on epithelial cells of the intestinal mucosa may clarify the pathogenesis of gastrointestinal disorders in patients with AIDS (4, 12) and provide a mechanism for anorectal transmission of the virus (34) .
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